RS50776B - Medikamenti koji sadrže steroide i novi lek antiholinesteraze - Google Patents

Medikamenti koji sadrže steroide i novi lek antiholinesteraze

Info

Publication number
RS50776B
RS50776B YUP-899/04A YUP89904A RS50776B RS 50776 B RS50776 B RS 50776B YU P89904 A YUP89904 A YU P89904A RS 50776 B RS50776 B RS 50776B
Authority
RS
Serbia
Prior art keywords
optionally
medicaments containing
containing steroids
diastereomers
anticholinesterase drug
Prior art date
Application number
YUP-899/04A
Other languages
English (en)
Inventor
Rolf Banholzer
Helmut Meissner
Michel Pairet
Gerald Pohl
Richard Reichl
Georg Speck
Christopher John Montague Meade
Gerd Morschhaeuser
Michael P. Pieper
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority to MEP-542/08A priority Critical patent/MEP54208A/xx
Publication of RS89904A publication Critical patent/RS89904A/sr
Publication of RS50776B publication Critical patent/RS50776B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Lek, naznačen time, što sadrži jednu ili više, prvenstveno jednu so formule 1 u kojojX- označava jednostavan, negativno naelektrisan anjon, prvenstveno neki anjon, odabran iz grupe koju čine hlorid, bromid, jodid, sulfat, fosfat, metansulfonat, nitrat. maleat, acetat, citrat, fumarat, tartarat, oksalat, sukcinat, benzoat i p-toluolsulfonat, u kombinaciji sa jednim ili sa više, prvenstveno sa jednim steroidom 2, u datom slučaju, u obliku svojih dijasteromera, smeše dijastereomera, ili u obliku racemata, u datom slučaju, u obliku solvata ili hidrata, kao i, u datom slučaju, sa nekim farmaceuski prihvatljivim pomoćnim sredstvom.Prijava sadrži još 19 patentnih zahteva.
YUP-899/04A 2002-04-12 2003-04-09 Medikamenti koji sadrže steroide i novi lek antiholinesteraze RS50776B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-542/08A MEP54208A (en) 2002-04-12 2003-04-09 Medicaments containing steroids and a novel anticholinesterase drug

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216429A DE10216429A1 (de) 2002-04-12 2002-04-12 Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
PCT/EP2003/003668 WO2003086399A1 (de) 2002-04-12 2003-04-09 Arzneimittel enthaltend steroide und ein neues anticholinergikum

Publications (2)

Publication Number Publication Date
RS89904A RS89904A (en) 2006-10-27
RS50776B true RS50776B (sr) 2010-08-31

Family

ID=28458802

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-899/04A RS50776B (sr) 2002-04-12 2003-04-09 Medikamenti koji sadrže steroide i novi lek antiholinesteraze

Country Status (29)

Country Link
EP (2) EP1621197A3 (sr)
JP (1) JP4559086B2 (sr)
KR (1) KR101010869B1 (sr)
CN (1) CN1646126A (sr)
AR (1) AR039275A1 (sr)
AT (1) ATE312607T1 (sr)
AU (1) AU2003216921B2 (sr)
BR (1) BR0309085A (sr)
CA (1) CA2481268C (sr)
DE (2) DE10216429A1 (sr)
DK (1) DK1496902T3 (sr)
EA (1) EA008386B1 (sr)
EC (1) ECSP045355A (sr)
ES (1) ES2254917T3 (sr)
HR (1) HRP20040943B1 (sr)
IL (2) IL164391A0 (sr)
ME (1) MEP54208A (sr)
MX (1) MXPA04009917A (sr)
MY (1) MY137045A (sr)
NO (1) NO20044097L (sr)
NZ (1) NZ536284A (sr)
PE (1) PE20040326A1 (sr)
PL (1) PL211227B1 (sr)
RS (1) RS50776B (sr)
TW (1) TWI311055B (sr)
UA (1) UA80125C2 (sr)
UY (1) UY27758A1 (sr)
WO (1) WO2003086399A1 (sr)
ZA (1) ZA200406751B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP4819699B2 (ja) * 2004-02-06 2011-11-24 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2435023B1 (en) 2009-05-29 2016-07-06 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta 2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
AU2014228414B2 (en) 2013-03-15 2018-09-13 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN115282411A (zh) * 2022-01-14 2022-11-04 温州医科大学 利用鼻嗅区递送药物入脑的输送系统及其应用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
SE8603252L (sv) 1985-07-30 1987-01-31 Glaxo Group Ltd Anordning for att tillfora lekemedel till patienter
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
WO1996033973A1 (fr) * 1995-04-28 1996-10-31 Banyu Pharmaceutical Co., Ltd. Derives disubstitues en position 1,4 de piperidine
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
JP2004512359A (ja) * 2000-10-31 2004-04-22 ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト 抗コリン作用薬及びコルチコステロイドをベースとする新規医薬組成物

Also Published As

Publication number Publication date
ECSP045355A (es) 2005-01-28
PE20040326A1 (es) 2004-07-13
DK1496902T3 (da) 2006-05-08
MY137045A (en) 2008-12-31
KR101010869B1 (ko) 2011-01-26
ZA200406751B (en) 2006-12-27
PL211227B1 (pl) 2012-04-30
EA200401303A1 (ru) 2005-04-28
ATE312607T1 (de) 2005-12-15
IL164391A0 (en) 2005-12-18
PL371561A1 (en) 2005-06-27
AR039275A1 (es) 2005-02-16
CA2481268C (en) 2011-07-12
NZ536284A (en) 2006-11-30
EP1496902A1 (de) 2005-01-19
DE50301934D1 (de) 2006-01-19
CA2481268A1 (en) 2003-10-23
AU2003216921A1 (en) 2003-10-27
EP1496902B1 (de) 2005-12-14
EP1621197A2 (de) 2006-02-01
EA008386B1 (ru) 2007-04-27
KR20050000391A (ko) 2005-01-03
MXPA04009917A (es) 2004-12-07
WO2003086399A1 (de) 2003-10-23
NO20044097L (no) 2004-11-04
TW200403062A (en) 2004-03-01
IL164391A (en) 2010-11-30
TWI311055B (en) 2009-06-21
CN1646126A (zh) 2005-07-27
RS89904A (en) 2006-10-27
UY27758A1 (es) 2003-11-28
UA80125C2 (en) 2007-08-27
BR0309085A (pt) 2005-02-09
HRP20040943A2 (en) 2005-04-30
AU2003216921B2 (en) 2008-03-13
JP2005529105A (ja) 2005-09-29
HRP20040943B1 (hr) 2013-05-31
ES2254917T3 (es) 2006-06-16
MEP54208A (en) 2011-05-10
DE10216429A1 (de) 2003-10-23
EP1621197A3 (de) 2010-01-06
JP4559086B2 (ja) 2010-10-06

Similar Documents

Publication Publication Date Title
HRP20080140T3 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
CO5540380A2 (es) Medicamentos inhalativos que contienen un nuevo anticolinergico en combinacion con corticosteroides y betamimeticos
RS50776B (sr) Medikamenti koji sadrže steroide i novi lek antiholinesteraze
MY130803A (en) New quinuclidine amide derivatives
BRPI0515885A (pt) derivados de ftalazinona, sua preparação e uso como agentes farmacêuticos
NO20065904L (no) Terapeutiske forbindelser
WO2005011657A3 (en) Piperazine derivatives and their use as therapeutic agents
AR035589A1 (es) Esteres de acido difenilmetilcarboxilico con efecto anticolinergico, un procedimiento para su preparacion, el uso de los mismos para la preparacion de un medicamento y los preparados farmaceuticos que los contienen
NO20044751L (no) Preparat og fremgangsmate for dosering av liposomer av bestemte storrelser for a behandle eller hindre sykdom
RU94013439A (ru) Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
GEP20043324B (en) Purine Derivatives
HUP0402217A2 (hu) Platinaszármazékot tartalmazó gyógyászati készítmények
MY129512A (en) Novel medicament compositions, based on tiotropium bromide and salmeterol
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
TW200607807A (en) Macrocyclic beta-secretase inhibitors
UA85541C2 (ru) Карбаматные производные хинуклидина и фармацевтическая композиции, которая содержит эти соединения
IL175334A (en) Use of a hydroximic acid halide derivative in the preparation of a medicament for the treatment of neurodegenerative diseases and composition comprising same
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
HUP9701777A2 (hu) Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására
NO975028L (no) Piperazinoderivater som neurokininantagonister
RU2008108302A (ru) Применение солей тиотропия для лечения тяжелых форм персистирующей астмы
DE602004022783D1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
DE50302675D1 (de) Neue arzneimittelkompositionen auf der basis neuer anticholinergika und egfr-kinase hemmern